Join today to receive exclusive benefits.
View my membership
President's blog

We were pleased to have Dr. Daniel Schwartz from CMS present at CEoT 2017 as part of our “Transplant Value- How to Survive the Next Decade” session. Dr. Schwartz focused his presentation on...


The REMS for NULOJIX (belatacept) was originally approved by the Food and Drug Administration (FDA) on June 15, 2011. On May 9, 2017, the FDA determined that a REMS is no longer required for NULOJIX and has eliminated the REMS requirement.

American Journal of Transplantation (AJT)

AJT is the joint journal of the AST and the ASTS. Access your subscription here.



The AST has been instrumental in assisting federal and state public policy decision-makers in the crafting and formation of a variety of legislative and regulatory initiatives.

We know transplant professionals like you are passionate about ensuring that patients have access to essential medicines, insurance coverage, and the best care possible.

Learn More
member spotlight

Jonathan Hand, MD

Speciality: Infectious Diseases

Graduated from: LSU-HSC Medical School New Orleans, MD; The Icahn School of Medicine at Mount Sinai Hospital Internal Medicine Residency and Infectious Diseases Fellowship

Current position: Director, Antimicrobial Stewardship Program Ochsner Medical Center; Assistant Professor, The University of Queensland School of...


This book covers the basic functionality of the immune system, the latest developments in immunosupressive drugs and protocols, and emerging technologies in the field.


Non adherence is a major problem in adolescent solid organ transplant recipients, leading to graft failure and loss, as well as interference with successful transition into adult care. In this podcast, Dr. Kurt...